BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Mergers and Acquisitions
Chromatin, Inc. Acquires Sorghum Production And Supply Company, Production Seeds Plus, Inc. 7/23/2014
Waters Corporation (WAT) Acquires REIMS Technology, Strengthens Health Science Initiative 7/23/2014
Welichem Announces Termination Of Asset Purchase Agreement And Update On Compulsory Acquisition 7/23/2014
Cancer Genetics, Inc. (CGIX) Announces Acquisition Of Gentris Corporation, A Leading Global Pharmacogenomics Company, And Increases Contract Backlog To Over $18 Million 7/22/2014
Teva Pharmaceutical Industries Limited (TEVA) Completes Acquisition Of Labrys: Opens Door To A Strong And Novel Migraine Prevention And Treatment Franchise Within Its CNS Portfolio 7/21/2014
Stallergenes, S.A. (GENP.PA) Expands Latin American Presence With Acquisition Of Alergo Pharma S.R.L. In Argentina 7/21/2014
ABL, Inc. Acquires Majority Interest In Platine Pharma Services 7/21/2014
Roche (RHHBY) CEO Plans To Steer Clear Of Big Acquisitions 7/21/2014
AbbVie (ABBV) Finally Clinches Shire For $54 Billion 7/21/2014
Gentiva Health Services (GTIV) Grabs $634 Million Bid, Rejects Kindred Bio (KIN)'s Stake Offer 7/18/2014
Symplmed Completes Ownership Of Perindopril Franchise With Acquisition Of ACEON® 7/18/2014
Perrigo Co. (PRGO) Mum On Published Merger Rumors, Potential Target For Abbott Laboratories (ABT) 7/17/2014
Pfizer Inc. (PFE) Snags INNOPHARMA In $360 Million Deal 7/17/2014
Thermo Fisher Scientific (TMO) To Sell Cole-Parmer Instrument Company For $480 Million 7/17/2014
Novartis AG (NVS), BWK Sell Stakes In Patch Maker LTS Lohmann Therapie-Systeme AG, Pockets $400 Million From Sale 7/17/2014
Sanofi (France) (SAN.PA) Quietly Held Talks With Abbott Laboratories (ABT), Mylan Inc. (MYL) About Mature Drugs 7/17/2014
Yibai Pharma To Acquire Horus C&K Pharma For $128 Million 7/16/2014
Investor Believes Roche (RHHBY) May Buy Exelixis, Inc. (EXEL) For Skin Cancer Drug 7/16/2014
Shire Ready To Bow To AbbVie (ABBV)'s Increased $53 Billion Offer 7/15/2014
Anthera Pharmaceuticals, Inc. (ANTH) Announces Acquisition Of Sollpura® (liprotamase) For Exocrine Pancreatic Insufficiency From Eli Lilly and Company (LLY) 7/15/2014
Chiltern Acquires Ockham And The Companies Merge Operations 7/15/2014
EPIRUS Biopharmaceuticals And Zalicus Inc. (ZLCS) Complete Merger - Combined Company Will Trade As EPIRUS Biopharmaceuticals 7/15/2014
Phlexglobal Announces Acquisition By Bridgepoint Development Capital 7/15/2014
Hikma Pharmaceuticals Completes The Acquisition Of Assets Of Bedford Laboratories 7/15/2014
Abbott Laboratories (ABT) Unloads Developed Markets Generics Unit To Mylan Inc. (MYL) For $5.3 Billion 7/14/2014
Ventrus Biosciences, Inc.  (VTUS) Becomes Assembly Biosciences As Stockholders Approve Merger With Assembly Pharmaceuticals 7/14/2014
ATS Labs, Inc. Announces the Acquisition Of MicroTest Labs, Inc. 7/14/2014
Lake Consumer Products Acquires License To Bring vH Essentials PMS Relief Product To Market 7/11/2014
BioTie Therapies Corp. Will Not Exercise Option To Buy Neurelis, Neurelis Regains Rights To Intranasal Diazepam Program 7/11/2014
Valeant Pharmaceuticals International (VRX) Completes Sale Of Filler And Toxin Assets To Galderma 7/10/2014
AbbVie (ABBV) Forced To Retract Claims Of Shire Investor Support 7/9/2014
NeoGenomics, Inc. (NGNM.OB) Completes Acquisition Of Path Logic 7/9/2014
MabVax Therapeutics, Inc. And Telik, Inc. (TELK) Announce Closing Of Merger 7/9/2014
Salix Pharmaceuticals, Ltd. (SLXP) Scoops Up Cosmo Technologies For Tax Savings 7/9/2014
Baxter International, Inc. (BAX) Snags Orphan Drug-Focused Biopharma, AesRx For Undisclosed Amount 7/9/2014
Easton Pharmaceuticals (OP: EAPH) Announces Closing Of Agreement To Invest And Acquire Ownership Interest In AMFIL Technologies Inc. And The mPACT -GROzone Antimicrobial Systems Line Of Products 7/8/2014
Mariel Therapeutics Announces Definitive Agreement To Acquire Stryker Corporation  (SYK)'s BMP-7 Assets For Potential Use In Osteoarthritis And Organ Fibrosis 7/8/2014
$100 Million Triple Life Sciences Deal For Newly Formed Concept Life Sciences 7/8/2014
Valeant Pharmaceuticals International (VRX) Completes Acquisition Of PreCision Dermatology 7/8/2014
StoneCalibre Acquires Nucleic Acid Purification Products Manufacturer Edge BioSystems, Inc. 7/8/2014
AbbVie (ABBV)'s Battle For Shire: Why This Time It's Different 7/8/2014
Sarepta Therapeutics (SRPT) Quietly Buys Eisai Company, Ltd. (ESALY.PK)'s Vacant R&D Lab In Cambridge For $25 Million 7/7/2014
AbbVie (ABBV) To Dispatch Research Chief Jim Sullivan To London 7/7/2014
Genentech (RHHBY) To Pay Up To $1.7 Billion For San Diego Biotech Firm Seragon Pharmaceuticals 7/7/2014
Merus Labs International Inc. Agrees To Buy Dacha Strategic Metals Inc. 7/7/2014
Hospira, Inc. Completes Acquisition Of Orchid Chemicals & Pharmaceuticals Ltd.'s Active Pharmaceutical Ingredient Manufacturing And R&D Facility 7/7/2014
Jazz Pharmaceuticals plc (JAZZ) Wagers Up To $250 Million On Rare Disease Drug From Sigma-Tau Pharmaceuticals 7/3/2014
Bio-Techne Snags Novus Biologicals For $60 Million Cash 7/3/2014
IMPAX Laboratories, Inc. (IPXL) Acquires Two Products From Actavis (ACT) 7/3/2014
NicOx SA (COX.PA) Scoops Up Aciex Therapeutics In $120 Million Deal 7/2/2014
PAREXEL International (PRXL) Announces Acquisition Of ATLAS Medical Services, A Provider Of Clinical Research Services In Turkey 7/2/2014
Actavis (ACT) Announces Final Stockholder Merger Consideration Election Results In Connection With Forest Laboratories, Inc. (FRX) Acquisition 7/2/2014
Integrated DNA Technologies Acquires SURVEYOR® Nuclease Business From Transgenomic, Inc. (TBIO) 7/2/2014
Quintiles, Inc. (Q) Completes Acquisition Of Encore Health Resources 7/2/2014
Furiex Pharmaceuticals, Inc. (FURX) Stockholders Approve Acquisition By Actavis (ACT); Ukrainian Antimonopoly Committee Clears Proposed Merger 7/2/2014
Intrexon Corporation To Acquire Trans Ova Genetics 7/2/2014
Massachusett's bluebird bio (BLUE) Snaps Up Pregenen For Up To $139.9 Million 7/2/2014
Bay Area's Transcept Pharmaceuticals, Inc. (TSPT) Soars On Plans To Merge With Paratek Pharmaceuticals, Inc., Picks Up $93 Million Along The Way; Transcept Stock Up +19.60% At Market Close (July 1, 2014) 7/1/2014
Johnson & Johnson (JNJ) Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group 7/1/2014
Welichem Responds To Completion Of Take-Over Bid 7/1/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Receive U.S. FTC Clearance For Actavis' Proposed Acquisition Of Forest 7/1/2014
Actavis (ACT) Completes Forest Laboratories, Inc. (FRX) Acquisition 7/1/2014
ANI Pharmaceuticals, Inc. Buys Lithobid Extended Release Tablets From Noven Therapeutics For $12 Million 7/1/2014
AbbVie (ABBV) Takes Shire Courtship Trip To London 6/30/2014
Merz North America Pays $600 Million For Ultrasound Facelift Company Ulthera 6/30/2014
RedHill Biopharma Ltd. (RDHL) Acquires Phase 2 Oncology Drug MESUPRON® From Wilex AG (WL6.DE) 6/30/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Announce Preliminary Stockholder Merger Consideration Election Results 6/30/2014
BioAlliance Pharma And TopoTarget A/S Shareholders Approve Proposed Cross-Border Merger To Create Onxeo 6/30/2014
Big Investor Picks Up Large Stake In Allergan Inc. (AGN) To Push For Valeant Pharmaceuticals International (VRX) Merger 6/27/2014
Shire Entertained Many "Large Opportunities" Before AbbVie (ABBV) Bid 6/27/2014
Like GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Mulls Sale Of Older Drugs, Plans To Put Dengue Vaccine Program In Separate Unit 6/27/2014
AmerisourceBergen Corporation (ABC) Completes Acquisition Of Minority Interest In Profarma Distribuidora de Produtos Farmacêuticos S.A. 6/27/2014
Auxilium Pharmaceuticals (AUXL) To Merge With Canadian Biotech QLT Inc. (QLTI) 6/26/2014
Shire Pharmaceuticals (SHPG) Release: We Believe The Bids Could Go Higher, Or A Different Currency Is Required 6/25/2014
Shire Comments On AbbVie (ABBV)’s Unchanged Proposal 6/25/2014
AbbVie (ABBV) Urges Talks With Shire, May Have To Raise Bid To $51 Billion 6/25/2014
Valeant Pharmaceuticals International (VRX) Files Preliminary Proxy Statement For Special Meeting Of Shareholders To Approve Share Issuance In Proposed Acquisition Of Allergan Inc. (AGN) 6/25/2014
Warnex Inc. (CC:WNX) Received TSX-V Approval And Waives Due Diligence Condition To Amalgamation With Diagnos Inc. (ADK) 6/25/2014
Zalicus Inc. (ZLCS) And EPIRUS Biopharmaceuticals Agree Zalicus Stockholders To Own 19 Percent Of Combined Company Post-Merger 6/25/2014
Shire To Set Out AstraZeneca PLC (AZN)-Style Defense Against AbbVie (ABBV)'s $46 Billion Bid 6/24/2014
Endo Buys DAVA Pharmaceuticals For $575 Million 6/24/2014
H. Lundbeck A/S (LUN.CO) Completes Acquisition Of Chelsea Therapeutics, Inc. (CHTP) 6/24/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Announce Tentative Election Deadline Of June 27, 2014 6/24/2014
Abbott Laboratories (ABT) Scoops Up Russian Drugmaker Veropharm For Between $395 To $495 Million Cash 6/24/2014
Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Closes Transaction To Acquire International Rights To Synacthen® And Synacthen® Depot 6/23/2014
AbbVie (ABBV) Release: Shire Bid Could Move A Lot High Risk Puts Ceiling At £55/Share 6/23/2014
Valeant Pharmaceuticals International (VRX) Posts Fact-Based Answers To Refute Allergan's Misleading Statements 6/23/2014
Lundbeck Inc. (LUN.CO) Successfully Completes Tender Offer For Chelsea Therapeutics, Inc. (CHTP) 6/23/2014
Albany Molecular Research, Inc. (AMRI) (AMRI) Announces Early Termination Of HSR Waiting Period For Acquisition Of OSO BioPharmaceuticals Manufacturing, LLC 6/23/2014
Emdeon Corporation (HLTH) To Acquire Capario To Enhance Its Revenue Management Platform 6/23/2014
Merger Of Simbec & Orion Corporation To Create A New International Full-Service CRO 6/23/2014
Allergan Inc. (AGN) Board Of Directors Unanimously Rejects Unsolicited Exchange Offer From Valeant Pharmaceuticals International (VRX) 6/23/2014
Shire plc Release: Management Spurns Three Offers From AbbVie (ABBV) , Fighting For Irish Independence, Call Monday Morning 6/23/2014
To Fend Off Pfizer Inc. (PFE), AstraZeneca PLC (AZN) Contemplating Sale Of Some Future Revenue From Existing Drugs 6/23/2014
Third Time Is Not The Charm As AbbVie (ABBV)'s $46 Billion Bid For Irish Rival Shire Rejected 6/23/2014
Cancer Genetics, Inc. (CGIX) Scoops Up Gentris Corporation In $4.75 Million Deal 6/23/2014
Celsion Corporation (CLN) Completes Acquisition Of EGEN, Inc. 6/20/2014
Rumor: Pfizer Inc. (PFE) May Be Interested In Buying Bristol-Myers Squibb Company (BMY) After Losing AstraZeneca PLC (AZN) 6/20/2014
Akorn, Inc. (AKN) Divests ECR Pharmaceuticals To Valeant Pharmaceuticals International (VRX) For $41 Million Cash 6/20/2014
Merck & Co., Inc. (MRK) Begins Tender Offer To Acquire Idenix Pharmaceuticals, Inc. (IDIX) 6/20/2014
While Valeant Pharmaceuticals International (VRX) Fights For Allergan Inc. (AGN), Allergan Takeover Bid For Shire "Imminent" 6/19/2014
New Drugs To Help Maintain Independence, Ward Off M&A Prospects: Actelion Ltd. (ALIOF.PK) CEO 6/19/2014
Allergan Inc. (AGN) Board Of Directors To Review Unsolicited Exchange Offer From Valeant Pharmaceuticals International (VRX) 6/18/2014
Actavis (ACT) And Forest Laboratories, Inc. (FRX) Shareholders Approve Proposals Related To Actavis' Planned Acquisition Of Forest 6/18/2014
Irish-Based Shire Braces For Takeover Bids 6/18/2014
MRC Technology Sells Its Melanocortin Receptors Programme To Pfizer Inc. (PFE) 6/18/2014
Allergan Inc. (AGN) Releases Personal Emails From Morgan Stanley (MST) Calling Valeant Pharmaceuticals International (VRX) A "House Of Cards" 6/18/2014
BioClinica, Inc. Acquires Blueprint Clinical, Inc. 6/16/2014
Merck & Co., Inc. (MRK) Open To More Biotech Deals After Idenix Pharmaceuticals, Inc. (IDIX): Research Chief 6/16/2014
Pfizer Inc. (PFE) CFO Reveals Money Killed AstraZeneca PLC (AZN) Deal 6/16/2014
AbbVie (ABBV) And Johnson & Johnson (JNJ) Were In A Bidding War For Idenix Pharmaceuticals, Inc. (IDIX), Will Achillion Pharmaceuticals, Inc. (ACHN) Be The Next Target? 6/13/2014
In Bid For Allergan Inc. (AGN), Valeant Pharmaceuticals International (VRX) Defends Its Record On Research 6/12/2014
Hyperion Therapeutics Completes Acquisition Of Andromeda Biotech 6/12/2014
Commentary: BioSpace (DHX) Readers Sound Off On Big Pharma Takeovers 6/12/2014
Roche (RHHBY) Markets 5 Buildings On New Jersey Campus, Razing The Rest 6/11/2014
Can Pfizer Inc. (PFE) Curb Its Appetite For Big Acquisitions? 6/11/2014
Spotlight Innovation Subsidiary Celtic Biotech Iowa, Inc. Completes Merger With Celtic Biotech Ltd. 6/11/2014
Merck & Co., Inc. (MRK) Snags Cambridge's Idenix Pharmaceuticals, Inc. (IDIX) For $3.85 Billion 6/11/2014
Activist Investor Ackman Says Allergan Inc. (AGN) Investors Back Takeover At $180 A Share 6/10/2014
Celsion Corporation (CLN) Scoops Up Privately-Held EGEN For $14 Million Including Debts 6/10/2014
NovaDigm Therapeutics Strengthens Candida Vaccine Portfolio With Three New Antigens Via Series Of Rights Acquisitions 6/10/2014
Chelsea Therapeutics, Inc. (CHTP) Announces The Expiration Of The Hart-Scott-Rodino Waiting Period In Relation To The Proposed Acquisition Of Chelsea Therapeutics By H. Lundbeck A/S (LUN.CO) 6/6/2014
VWR International, Inc. Acquires LABREPCO, Inc. 6/4/2014
Cantel Medical (CMN) Smacks Down $26.9 Million Cash For PuriCore 6/4/2014
Repligen Corporation (RGEN) Scoops Up Small New Jersey Firm Refine Technology For $24.5 Million Cash/Stock Deal 6/4/2014
Teva Pharmaceutical Industries Limited (TEVA) Buys Privately Held Labrys Biologics In Deal Worth $825 Million 6/4/2014
Valeant Pharmaceuticals International (VRX), Pershing Square Go Hostile In $53.8 Billion Allergan Inc. (AGN) Bid 6/3/2014
Rumor: Shire Mulls Over A $4 Billion Bid For U.S.-Based NPS Pharmaceuticals, Inc. (NPSP) 6/3/2014
NPS Pharmaceuticals, Inc. (NPSP) Denies Any Contact From Shire Over Possible Takeover 6/3/2014
Asana Biosciences, An Amneal Alliance Company, Acquires Branded Drug Discovery Platform From Endo International Plc 6/3/2014
Albany Molecular Research, Inc. (AMRI) (AMRI) Ponies Up $110 Million For OSO BioPharmaceuticals Manufacturing, LLC 6/2/2014
Sequenom Inc. (SQNM) Reports Sale Of bioscience Corporation Business 6/2/2014
Aastrom Biosciences, Inc. (ASTM) Completes Acquisition Of Sanofi (France) (SAN.PA)'s Cell Therapy And Regenerative Medicine Business 6/2/2014
Ohr Pharmaceutical (OHRP) Announces Closing Of SKS Ocular Acquisition; Strengthens Executive Management Team 6/2/2014
Endo Completes Sale Of Early Stage Drug Discovery Portfolio 6/2/2014
TiGenix Completes The Sale Of Its Dutch Manufacturing Facility To PharmaCell BV 6/2/2014
Zalicus Inc. (ZLCS) Announces Closing Of CHTS Service Business Sale To Horizon Discovery Group 6/2/2014
Oxford Gene Technology Ltd. To Sell Cytocell Products Direct In North America 6/2/2014
Easton Pharmaceuticals (OP: EAPH) Announces the Closing of Medical Marijuana Agreement With MDRM Group (Canada) Ltd., On Purchasing An Ownership Interest In A Growers License In Canada's Federal Medical Marijuana Industry 6/2/2014
Provence Technologies Acquires Synprosis 6/2/2014
Allergan Inc. (AGN) Comments On Pershing Square’s And Valeant Pharmaceuticals International (VRX)’s Attempt To Remove A Majority Of The Members Of The Allergan Board Of Directors 6/2/2014
GlaxoSmithKline (GSK) Hunts For Suitors To Buy Older Drugs, Eyes Cash To Focus On Most Lucrative Areas Of Business 6/2/2014
Top VIVUS, Inc. (VVUS) Shareholder Plans To Buy Company In $640 Million Deal 5/30/2014
Pfizer Inc. (PFE) Officially Ditches Pursuit Of AstraZeneca PLC (AZN) 5/29/2014
Allergan Inc. (AGN) Attacks Valeant Pharmaceuticals International (VRX)'s Business Strategy 5/29/2014
Valeant Pharmaceuticals International (VRX) Cranks Up Its Offer For Allergan Inc. (AGN) 5/28/2014
ILC Dover Acquires JetSolutions SA 5/28/2014
Valeant Pharmaceuticals International (VRX) Unloads Filler And Toxin Assets To Nestle SA For $1.4 Billion Cash 5/28/2014
Hikma Pharmaceuticals Buys Boehringer Ingelheim Corporation Injectable Drugs Business Bedford Laboratories For Up To $300 Million 5/28/2014
Telerx To Acquire C3i, A Life Science Technology Services And Solutions Provider, Adding Global Capabilities 5/27/2014
Inovio Pharmaceuticals (INO) Subsidiary Sells Animal Health Assets 5/27/2014
Sweden's Lund University Acquires Biomass Pretreatment Reactor From AdvanceBio Systems 5/27/2014
Recordati S.p.A Finalizes The Second Tranche Of Its Acquisition Of Opalia Pharma In Tunisia 5/27/2014
Allergan Inc. (AGN) Files Investor Presentation Detailing Concerns About The Sustainability Of Valeant Pharmaceuticals International (VRX)’s Business Model 5/27/2014
Loophole Offers Pfizer Inc. (PFE) A Risky Way Back Into A Deal With AstraZeneca PLC (AZN) 5/23/2014
H. Lundbeck A/S (LUN.CO) Commences Tender Offer For All Outstanding Shares Of Chelsea Therapeutics, Inc. (CHTP) 5/23/2014
BioAlliance Pharma, TopoTarget A/S To Merge, Combined Entity To Be Named Onxeo 5/22/2014
Sarepta Therapeutics (SRPT) Announces Agreement For Acquisition Of Manufacturing Facility In Massachusetts 5/22/2014
Clarification Regarding Pfizer Inc. (PFE) Statement 5/21/2014
Supreme Pharmaceuticals Inc. Announces Second Acquisition Target 5/21/2014
AstraZeneca PLC (AZN) Rejects Pfizer Inc. (PFE)'s Final Offer 5/20/2014
Boston Scientific Corporation (BSX) Pays $415 Million For Bayer AG (BAYZF) Unit 5/19/2014
Endo Completes Acquisition Of Rights To Sumavel® DosePro® 5/19/2014
Ventrus Biosciences, Inc.  (VTUS) To Merge With Assembly Pharmaceuticals 5/19/2014
Senesco Technologies, Inc. (SNT) Completes Acquisition Of Fabrus LLC 5/19/2014
Ohr Pharmaceutical (OHRP) Announces Agreement To Acquire Technology Assets Of SKS Ocular 5/16/2014
Abbott Laboratories (ABT) Expands Latin American Presence And Branded Generics Portfolio With Acquisition Of CFR Pharmaceuticals 5/16/2014
Meridex Announces Agreement To Acquire Biogen Sciences Inc 5/16/2014
Pfizer Inc. (PFE) Exec Claims AstraZeneca PLC (AZN) Deal Will Not Put Lives At Risk 5/15/2014
AstraZeneca PLC (AZN) Leaves Door Ajar To Pfizer Inc. (PFE), Despite Hurdles 5/15/2014
GlaxoSmithKline (GSK), Pernix Therapeutics, Inc. (PTX) Ink $250 Million Migraine Drug Deal 5/15/2014
Valeant Pharmaceuticals International (VRX) Will Sweeten $46 Billion Allergan Inc. (AGN) Bid 5/14/2014
Eurofins Shells Out $255 Million For U.S. Diagnostic Testing Company 5/14/2014
Allergan Inc. (AGN) Rejects Valeant Pharmaceuticals International (VRX)'s Takeover Offer 5/13/2014
KBI BioPharma Acquires Biologics Operations In Colorado 5/13/2014
Telik, Inc. (TELK) And MabVax Therapeutics, Inc. Announce Definitive Merger Agreement 5/13/2014
Origin Agritech Limited (SEED) Announces Receipt Of Acquisition Proposal 5/13/2014
Inovio Pharmaceuticals (INO) Acquires Early Stage DNA Therapies To Treat Alzheimer's And Multiple Sclerosis 5/13/2014
Merck & Co., Inc. (MRK) Signs Sale Agreement With Santen Pharmaceutical For Merck's Ophthalmology Products In Japan And Key Markets In Europe And Asia Pacific 5/13/2014
Pfizer Inc. (PFE) Presses AstraZeneca PLC (AZN) Case As CEO Faces UK Grilling 5/13/2014
Shire Pharmaceuticals (SHPG) To Acquire Lumena Pharmaceuticals For Upfront Payment Of $260 Million In Cash 5/13/2014
Pfizer Inc. (PFE)'s Bid For AstraZeneca PLC (AZN) Shows That Big Pharma Is As Rotten As The Banks 5/13/2014
Merck KGaA (MKGAF.PK) Invests In Innovations For Future Growth 5/12/2014
Mallinckrodt Pharmaceuticals (MNK) And Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Announce Early Termination Of HSR Act Waiting Period 5/12/2014
Quintiles, Inc. (Q) Announces Agreement To Acquire Encore Health Resources 5/12/2014
Merck & Co., Inc. (MRK) Taking A Break From Dealmaking: CEO 5/9/2014
Akorn, Inc. (AKN) Picks Up VersaPharm For $440 Million 5/9/2014
Lundbeck Inc. (LUN.CO) Swallows Up Chelsea Therapeutics, Inc. (CHTP) In Deal Worth $658 Million 5/9/2014
Taking A Swipe At Mylan Inc. (MYL), MEDA Preys On Its Own M&A Opportunities 5/8/2014
ICON Completes Acquisition Of Aptiv Solutions 5/8/2014
Medican Announces Final Approval Of Acquisition Terms 5/8/2014
AstraZeneca PLC (AZN) Shares Back On Rise Amid Fresh Bid Speculation 5/8/2014
Despite Repeated Rebuffs, Teva Pharmaceutical Industries Limited (TEVA) Woos Cipla Ltd. With $6 Billion Offer 5/8/2014
Auven Therapeutics (previously known as Celtic Therapeutics Management L.L.L.P.) And BELLUS Health Announce Engagement Of Financial Advisor To Explore Sale Of KIACTA™, An Experimental Drug In Phase 3 Development For The Treatment Of AA Amyloidosis 5/7/2014
Pfizer Inc. (PFE) Execs Claim AstraZeneca PLC (AZN) Takeover Could Improve R&D 5/7/2014
Pfizer Inc. (PFE) Hints At Potential Hostile Move For AstraZeneca PLC (AZN) 5/7/2014
Merck & Co., Inc. (MRK) May Use Bayer AG (BAYZF) Cash To Hunt For Companies With Promising Experimental Drugs 5/7/2014
Ackman Warns Allergan Inc. (AGN): Back Away From Other Potential Buyers 5/7/2014
Hong Kong's Tigermed Pays $50.25 Million Cash For Control Of Frontage Laboratories 5/7/2014
Bayer AG (BAYZF) Finally Bags Merck & Co., Inc. (MRK)'s Consumer Biz For $14.2 Billion 5/7/2014